Counting the costs of MS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1441, 2004-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Counting the costs of MS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 455, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Counting the Costs of Drug-Related Adverse Events

By White T.J.

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 445-458

Adis International

Access to resources Recommend Favorite

Counting costs of diabetes? Better start early . . .

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Application of In-Line Liquid Chromatography-Accurate Radioisotope Counting-Mass Spectrometry (LC-ARC-MS) to Evaluate Metabolic Profile of [3H]-Mefenamic Acid in Rat Plasma

Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. : 179-188

Bentham Science Publishers

Access to resources Recommend Favorite

A decision by Spanish Health Minister Ms Ana Pastor to decrease costs of drug spending within the country's NHS has added to pressure already felt by drug manufacturers

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite